Back to companies
Viridian Therapeutics, Inc.\DE
VRDNUSNASDAQPharmaceuticals & HealthcareViridian Therapeutics, Inc.\DE
Revenue
$70.8mn
YoY +23359.9%
Operating income
-$363.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API